The prevalence of non-communicable diseases (NCDs), such as cardiovascular ... ensure the arteries remain open throughout the ...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final two rounds ...
Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients ...
The ELEGANCE registry, which is focused on historically underrepresented minorities and women, analyzed endovascular treatment ...
The 2024 edition of Transcatheter Cardiovascular Therapeutics (TCT) once again highlighted significant innovations in ...
Drug Eluting Device Market: Market Size, Trends, Opportunities and Forecast by Application, Material Type, End-User, Region, By Country: 2020-2030" report has been added to ResearchAndMarkets.com's ...
Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients ...
Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients undergo cardiac stenting procedures does not improve outcomes, a Mount Sinai-led ...
Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients ...
The system has CE mark but remains investigational in the U.S. “Despite decades of innovation, drug-eluting stents and ...
Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, today announced late-breaking data demonstrating significant b ...
In advance of a regulatory proposal amending the Food and Drug Regulations to simplify market access for non-prescription drug products, Health Canada has developed a Non-prescription Drug (NPD) ...